REQUEST A DEMO
Total
USD $0.00
Search more companies

Au galen Pharm (Serbia)

Main Activities: Department Stores
Full name: Au galen Pharm Profile Updated: October 13, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Au galen Pharm is an enterprise based in Serbia. Its main office is in Belgrade. The company operates in the Department Stores industry. It was first established on 2007. Au galen Pharm currently employs 360 (2019) people. In 2022, the company reported a net sales revenue increase of 11.69%. Its’ total assets recorded a growth of 18.2%. In, 2022, the company’s net profit margin decreased by 0.68%.

Headquarters
Beogradska 8
Belgrade; Belgrade; Postal Code: 11080

Contact Details: Purchase the Au galen Pharm report to view the information.

Website: http://www.galenpharm.com

Basic Information
Total Employees:
Purchase the Au galen Pharm report to view the information.
Outstanding Shares:
Purchase the Au galen Pharm report to view the information.
Registered Capital:
Purchase the Au galen Pharm report to view the information.
Incorporation Date:
2007
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Pharmaval
100%
Company Performance
Financial values in the chart are available after Au galen Pharm report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
11.69%
Total operating revenue
11.07%
Operating profit (EBIT)
-43.8%
EBITDA
-23.1%
Net Profit (Loss) for the Period
-49.38%
Total assets
18.2%
Total equity
7.85%
Operating Profit Margin (ROS)
-0.91%
Net Profit Margin
-0.68%
Return on Equity (ROE)
-8.23%
Debt to Equity Ratio
19.1%
Quick Ratio
-0.1%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?